Understanding how branched amino acids affect insulin resistance and cardiovascular health
Keeping fat out of muscle - Role of Branched Amino AcidsAmino Acids in Insulin Resistance
This study is looking at how certain nutrients called branched-chain amino acids (BCAAs) can help people with type 2 diabetes by improving their insulin sensitivity and heart health, and it aims to find new ways to make this happen.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10914250 on NIH RePORTER |
What this research studies
This research investigates the role of branched-chain amino acids (BCAAs) in insulin resistance and their impact on cardiovascular health. It explores how increasing the breakdown of BCAAs can improve insulin sensitivity, which is crucial for managing type 2 diabetes. The study involves both laboratory experiments and potential pharmaceutical developments aimed at enhancing BCAA metabolism. By examining the mechanisms behind these processes, the research aims to uncover new treatment strategies for insulin resistance and related cardiovascular issues.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with type 2 diabetes or those exhibiting signs of insulin resistance.
Not a fit: Patients without insulin resistance or type 2 diabetes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that improve insulin sensitivity and reduce the risk of cardiovascular complications in patients with type 2 diabetes.
How similar studies have performed: Previous studies have shown promising results in targeting BCAA metabolism for improving insulin resistance, indicating that this approach has potential for success.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Arany, Zoltan P — University of Pennsylvania
- Study coordinator: Arany, Zoltan P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.